Literature DB >> 6308475

Long-term regenerated nerve fibres retain sensitivity to potassium channel blocking agents.

J D Kocsis, S G Waxman.   

Abstract

Mammalian myelinated peripheral nerve fibres display a remarkable degree of regeneration following a discrete nerve crush. Nerve crush disrupts the axon cylinder, but leaves the basement membrane of the Schwann cell intact. These intact endoneurial tubes provide pathways to guide the regenerating axon sprouts. After contact with the periphery is established, the regenerating fibres enlarge and myelinate. Conduction velocity recovers to nearly normal and functional recovery is, in many cases, nearly complete. A distinct feature of normal mature myelinated axons is the insensitivity of these fibres to potassium channel blocking agents. In contrast, immature myelinated axons are exquisitely sensitive to the K channel blocking agent 4-aminopyridine (4-AP). Application of 4-AP to immature myelinated fibres leads to a delayed membrane depolarization with action potential burst activity in response to a single stimulus. This sensitivity to 4-AP is attenuated as the fibres mature. Previous studies have demonstrated a sensitivity to 4-AP in regenerating nerve fibres; this sensitivity differentiates the regenerating axon segments from their normal parent axon segments. Such studies have not, however, examined the question of whether regenerated fibres, which have re-established peripheral connections and are functionally active, fully recapitulate the functional organization of normal mature myelinated fibres. We demonstrate here that while sensitivity to the potassium channel blocking agents 4-AP and 3, 4-diaminopyridine (3, 4-DAP) is lost in the normal course of myelinated axon maturation, this property is present in long-term regenerated axons. This suggests that long-term regenerated mammalian axons are characterized by a functional organization that bears a closer resemblance to that of immature myelinated fibres than to that of adult myelinated fibres.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6308475     DOI: 10.1038/304640a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  10 in total

1.  Persistent abnormalities of membrane excitability in regenerated mature motor axons in cat.

Authors:  Mihai Moldovan; Christian Krarup
Journal:  J Physiol       Date:  2004-08-05       Impact factor: 5.182

2.  Mechanisms of hyperpolarization in regenerated mature motor axons in cat.

Authors:  Mihai Moldovan; Christian Krarup
Journal:  J Physiol       Date:  2004-08-05       Impact factor: 5.182

3.  Current-clamp analysis of a time-dependent rectification in rat optic nerve.

Authors:  D L Eng; T R Gordon; J D Kocsis; S G Waxman
Journal:  J Physiol       Date:  1990-02       Impact factor: 5.182

4.  Function and distribution of three types of rectifying channel in rat spinal root myelinated axons.

Authors:  M Baker; H Bostock; P Grafe; P Martius
Journal:  J Physiol       Date:  1987-02       Impact factor: 5.182

5.  Aminopyridine-sensitivity of spinal cord white matter studied in vitro.

Authors:  J D Kocsis
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

6.  Functional specializations of primary auditory afferents on the Mauthner cells: interactions between membrane and synaptic properties.

Authors:  Sebastian Curti; Alberto E Pereda
Journal:  J Physiol Paris       Date:  2009-11-23

7.  Evolution of peripheral nerve function in humans: novel insights from motor nerve excitability.

Authors:  Michelle A Farrar; Susanna B Park; Cindy S-Y Lin; Matthew C Kiernan
Journal:  J Physiol       Date:  2012-09-24       Impact factor: 5.182

8.  Delayed depolarization and slow sodium currents in cutaneous afferents.

Authors:  O Honmou; D A Utzschneider; M A Rizzo; C M Bowe; S G Waxman; J D Kocsis
Journal:  J Neurophysiol       Date:  1994-05       Impact factor: 2.714

9.  Differential sensitivity of amphibian nodal and paranodal K+ channels to 4-aminopyridine and TEA.

Authors:  C L Schauf
Journal:  Experientia       Date:  1987-04-15

10.  Phase IIB Randomized Trial on the Use of 4-Aminopyridine in Guillain-Barré Syndrome.

Authors:  Jay M Meythaler; Robert C Brunner; Jean Peduzzi
Journal:  Arch Rehabil Res Clin Transl       Date:  2021-04-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.